Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A novel point mutation in the ND6 subunit of complex I at position 14,459 of the mitochondrial DNA (MTND6*LDY T14459A) was identified as a candidate mutation for the highly tissue-specific disease. Leber's hereditary optic neuropathy plus
dystonia
. Since the
MTND6*LDYT14459A
mutation was identified in a single family, other pedigrees with the mutation are needed to confirm its association with the disease. Clinical, biochemical, and genetic characterization is reported in two additional pedigrees. Leber's hereditary optic neuropathy developed in two family members in one pedigree. The daughter had clinically silent basal ganglia lesions. In a second pedigree, a single individual presented with childhood-onset generalized
dystonia
and bilateral basal ganglia lesions. Patient groups that included individuals with Leigh's disease,
dystonia
plus complex neurodegeneration, and Leber's hereditary optic neuropathy did not harbor the
MTND6*LDYT14459A
mutation, suggesting that this mutation displays a high degree of tissue specificity, thus producing a narrow phenotypic range. These results confirm the association of the
MTND6*LDYT14459A
mutation with Leber's hereditary optic neuropathy and/or
dystonia
. As the first genetic abnormality that has been identified to cause generalized
dystonia
, this mutation suggests that nuclear DNA or mitochondrial DNA mutations in oxidative phosphorylation genes are important considerations in the pathogenesis of
dystonia
.
...
PMID:Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. 765 63